Wird geladen...
CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma
Establishing the diagnosis of focal brain lesions in patients with unexplained neurologic symptoms represents a challenge. The goal of this study is to provide evidence supporting functional roles for CXC chemokine ligand (CXCL)13 and interleukin (IL)-10 in central nervous system (CNS) lymphomas and...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Artigo |
Sprache: | Inglês |
Veröffentlicht: |
American Society of Hematology
2013
|
Schlagworte: | |
Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3674672/ https://ncbi.nlm.nih.gov/pubmed/23570798 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2013-01-476333 |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|